Assessment of Ceruloplasmin, Hemopexin, and Haptoglobin in Asthmatic Children

  • Amany M. Abd Al-Aziz Department of Pediatric, National Research Centre, Cairo, Egypt
  • Hala Shaaban Department Pediatric, Faculty of Medicine, Cairo University, Cairo, Egypt
  • Ahmed Talaat Department of Pediatric, National Research Centre, Cairo, Egypt
  • Mona A. M. Awad Department Clinical and Chemical Pathology, National Research Centre, Cairo, Egypt
  • Radwa Ali Department of Pediatric, National Research Centre, Cairo, Egypt
  • Walaa A. Shahin Department Pediatric, Faculty of Medicine, Cairo University, Cairo, Egypt
Keywords: Iron homeostasis, Biological markers, Asthma pathogenesis

Abstract

BACKGROUND: Ceruloplasmin (Cp), haptoglobin, and hemopexin play a role in iron homeostasis and may function to modulate the systemic inflammatory response and be involved in tissue repair. We hypothesized that these proteins could be biological markers for bronchial asthma that reflect the involvement of iron oxidative stress in asthma pathogenesis.

AIM: Evaluation of serum levels of proteins involved in iron homeostasis (Cp, hemopexin, and haptoglobin) in asthmatic children and their correlation to pulmonary functions.

MATERIALS AND METHODS: Sixty moderate to severe persistent asthmatic children aged 6–13 years were included (30 during attacks and 30 in-between attacks). Thirty healthy matched controls were also recruited. All children were subjected to history taking, clinical evaluation and assessment of complete blood picture, serum levels of Cp, haptoglobin, hemopexin, and total IgE. Pulmonary function tests were assessed for all patients.

RESULTS: Serum Cp and haptoglobin were significantly elevated in asthmatic children between attacks (448.04 ± 386.79), (993.33 ± 554.56) compared to controls (168.42 ± 13.46), (473.33 ± 350.3), (p = 0.0002, p < 0.0001) and to asthmatics during exacerbations (288.8 ± 219.6), (620 ± 467.86), (p = 0.014, p = 0.006). Serum hemopexin was significantly higher in asthmatics between attacks (509.33 ± 341.51) compared to controls (296.67 ± 158.38) (p < 0.003) but no significant difference compared to acute exacerbations (477.33 ± 396.6). No significant correlations were found between any of the assessed protein levels and pulmonary functions. Hemoglobin concentration was significantly higher among stable asthmatics compared to acute exacerbation and control groups.

CONCLUSION: Cp, haptoglobin, and hemopexin can be used as a panel of non-invasive biomarkers that reflect the involvement of iron oxidative stress in asthma pathogenesis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

World Health Organization. Asthma Key Facts. Geneva: World Health Organization. Available from: https://www.who.int/respiratory/asthma/en.

D’Amato G, Salzillo A, Piccolo A, D’Amato M, Liccardi G. A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma. Ther Clin Risk Manag. 2007;3(4):613-9. https://doi.org/10.2174/1568010043343615 PMid:18472983

Wenzel SE. Asthma: Defining of the persistent adult phenotypes. Lancet. 2006;368(9537):804-13. https://doi.org/10.1016/s0140-6736(06)69290-8 PMid:16935691

Uwaezuoke SN, Ayuk AC, Eze JN. Severe bronchial asthma in children: A review of novel biomarkers used as predictors of the disease. J Asthma Allergy. 2018;11:11-8. https://doi.org/10.2147/jaa.s149577 PMid:29398922

Wadsworth S, Sin D, Dorscheid D. Clinical update on the use of biomarkers of airway inflammation in the management of asthma. J Asthma Allergy. 2011;4:77-86. https://doi.org/10.2147/jaa.s15081 PMid:21792321

Mumby S, Chung KF, McCreanor JE, Moloney ED, Griffiths MJ, Quinlan GJ. Pro-oxidant iron in exhaled breath condensate: A potential excretory mechanism. Respir Med. 2011;105(9):1290-5. https://doi.org/10.1016/j.rmed.2011.03.021 PMid:21514132

Verrills NM, Irwin JA, He XY, Wood LG, Powell H, Simpson JL, et al. Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(12):1633-43. https://doi.org/10.1164/rccm.201010-1623oc PMid:21471098

Fink MP. Editorial: Hemopexin: Newest member of the anti-inflammatory mediator club. J Leukoc Biol. 2009;86(2):203-4. https://doi.org/10.1189/jlb.0309137 PMid:19643739

Vassiliev V, Harris ZL, Zatta P. Ceruloplasmin in neurodegenerative diseases. Brain Res Brain Res Rev. 2005;49(3):633-40. https://doi.org/10.1016/j.brainresrev.2005.03.003 PMid:16269323

Lin T, Kwak YH, Sammy F, He P, Thundivalappil S, Sun G, et al. Synergistic inflammation is induced by blood degradation products with microbial toll-like receptor agonists and is blocked by hemopexin. J Infect Dis. 2010;202(4):624-32. https://doi.org/10.1086/654929 PMid:20617898

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. United States: Global Initiative for Asthma; 2012.

Cox DW, Tümer Z, Roberts EA. Copper transport disorders: Wilson disease and Menkes disease. In: Fernandes J, Saudubray JM, Van den Berghe G., editors. Inborn Metabolic Diseases. Berlin, Heidelberg: Springer; 2000. p. 384-91. https://doi.org/10.1007/978-3-662-04285-4_33

Wiggins JE, Goyal M, Wharram BL, Wiggins RC. Antioxidant ceruloplasmin is expressed by glomerular parietal epithelial cells and secreted into urine in association with glomerular aging and high-calorie diet. J Am Soc Nephrol. 2006;17(5):1382-7. https://doi.org/10.1681/asn.2005111239 PMid:16597684.

Baker CS, Evans TW, Haslam PL. Measurement of ceruloplasmin in the lungs of patients with acute respiratory distress syndrome: Is plasma or local production the major source? Respiration. 2000;67(5):533-8. https://doi.org/10.1159/000067469 PMid:11070458

Ermis B, Armutcu F, Gurel A, Kart L, Demircan N, Altin R, Demirel F. Trace elements status in children with bronchial asthma. Eur J Gen Med. 2004;1(1):4-8. https://doi.org/10.29333/ejgm/81766

Vural H, Uzun K. Serum and red blood cell antioxidant status in patients with bronchial asthma. Can Respir J. 2000;7(6):476-80. https://doi.org/10.1155/2000/907478 PMid:11121092

Farkhutdinov UR, Farkhutdinov SU. Efficacy of ceruloplasmin in patients with asthma. Ter Arkh. 2012;84(12):45-8. PMid:23479988

Van Rensen EL, Hiemstra PS, Rabe KF, Sterk PJ. Assessment of microvascular leakage via sputum induction: The role of substance P and neurokinin A in patients with asthma. Am J Respir Crit Care Med. 2002;165(9):1275-9. https://doi.org/10.1164/rccm.2110092 PMid:11991878

Yang F, Ghio AJ, Herbert DC, Weaker FJ, Walter CA, Coalson JJ. Pulmonary expression of the human haptoglobin gene. Am J Respir Cell Mol Biol. 2000;23(3):277-82. https://doi.org/10.1165/ajrcmb.23.3.4069 PMid:10970816

Kauffmann F, Frette C, Annesi I, Oryszczyn MP, Dore MF, Neukirch F. Relationships of haptoglobin level to FEV1, wheezing, bronchial hyper-responsiveness and allergy. Clin Exp Allergy. 1991;21(6):669-74. https://doi.org/10.1111/j.1365-2222.1991.tb03194.x PMid:1777829

Nishioka T, Uchida K, Meno K, Ishii T, Aoki T, Imada Y, et al. Alpha-1-antitrypsin and complement component C7 are involved in asthma exacerbation. Proteomics Clin Appl. 2008;2(1):46-54. https://doi.org/10.1002/prca.200780065 PMid:21136778

Larsen K, Macleod D, Nihlberg K, Gürcan E, Bjermer L, Marko-Varga G, et al. Specific haptoglobin expression in bronchoalveolar lavage during differentiation of circulating fibroblast progenitor cells in mild asthma. J Proteome Res. 2006;5(6):1479-83. https://doi.org/10.1021/pr050462h PMid:16739999.

Lamoureux A, Leclere M, Lemos K, Lefebvre J, Wagner B, Lavoie J. Systemic inflammation is present in both remission and clinical exacerbation in an equine model of severe asthma. Am J Resp Critic Care Med. 2011;183:A1322. https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1322

Kim CK, Chung CY, Koh YY. Changes in serum haptoglobin level after allergen challenge test in asthmatic children. Allergy 1998;53(2):184-9. https://doi.org/10.1111/j.1398-9995.1998.tb03868.x PMid:9534918

Koh YY, Kim YW, Park JD, Oh JW. A comparison of serum haptoglobin levels between acute exacerbation and clinical remission in asthma. Clin Exp Allergy 1996;26(10):1202-9. https://doi.org/10.1111/j.1365-2222.1996.tb00509.x PMid:8911708

Fröhlander N, Stjernberg N. Association between haptoglobin groups and hereditary predisposition for bronchial asthma. Hum Hered 1989;39(1):7-11. https://doi.org/10.1159/000153824 PMid:2474487

Krasteva A, Perenovska P, Ivanova A, Altankova I, Bocheva T, Kisselova A. Alteration in salivary components of children with allergic asthma. Biotechnol Biotechnol Equip. 2010;24(2):1866-9. https://doi.org/10.2478/v10133-010-0050-2

Sadrzadeh SM, Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am J Clin Pathol. 2004;121(Suppl):S97-104. https://doi.org/10.1309/8glx5798y5xhq0vw PMid:15298155

Haenen S, Clynen E, De Vooght V, Schoofs L, Nemery B, Hoet PH, et al. Proteome changes in auricular lymph nodes and serum after dermal sensitization to toluene diisocyanate in mice. Proteomics. 2012;12:3548-58. https://doi.org/10.1002/pmic.201200264 PMid:23038679

Monferran S, Paupert J, Dauvillier S, Salles B, Muller C. The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9. EMBO J. 2004;23:3758-68. https://doi.org/10.1038/sj.emboj.7600403 PMid:15385961

Araujo BB, Dolhnikoff M, Silva LF, Elliot J, Lindeman JH, Ferreira DS, et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J. 2008;32(1):61-9. https://doi.org/10.1183/09031936.00147807 PMid:18321931

Mak JC, Ho SP, Ho AS, Law BK, Cheung AH, Ho JC, et al. Sustained elevation of systemic oxidative stress and inflammation in exacerbation and remission of asthma. ISRN Allergy. 2013;2013:5618-31. https://doi.org/10.1155/2013/561831 PMid:24073339

Hussein A, Abdel Aziz S, Ahmed A. Imbalance between serum matrix metalloproteinase-9 and its inhibitor is associated with increased airway wall thickness in uncontrolled asthmatics. Egypt J Bronchol. 2012;6(1):37-43.

Muller-Eberhard U, Javid J, Liem HH, Hanstein A, Hanna M. Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood. 1968;32(5):811-5. https://doi.org/10.1182/blood.v32.5.811.811 PMid:5687939

Nielsen MJ, Moestrup SK. Receptor targeting of hemoglobin mediated by the haptoglobins: Roles beyond heme scavenging. Blood. 2009;114(4):764-71. https://doi.org/10.1182/blood-2009-01-198309 PMid:19380867

Morello N, Tonoli E, Logrand F, Fiorito V, Fagoonee S, Turco E, et al. Haemopexin affects iron distribution and ferritin expression in mouse brain. J Cell Mol Med. 2009;13(10):4192-204. https://doi.org/10.1111/j.1582-4934.2008.00611.x PMid:19120692

Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202(2):199-211. PMid:15629195

Lee SH, Kim KH, Kim JM, Yoon SH, Kim TH, Park SW, et al. Relationship between group-specific component protein and the development of asthma. Am J Respir Crit Care Med. 2011;184:528-36. https://doi.org/10.1164/rccm.201006-0951oc PMid:21169467.

Galez D, Dodig S, Raos M, Nogalo B. C-reactive protein in children with asthma and allergic rhinitis. Biochem Med. 2006;16(2):163-9. https://doi.org/10.11613/bm.2006.015

Razi E, Ehteram H, Akbari H, Chavoshi V, Razi A. Evaluation of high-sensitivity C-reactive protein in acute asthma. Tanaffos. 2012;11(1):32-7. PMid:25191398

Belda J, Margarit G, Martínez C, Casan P, Rodríguez-Jerez F, Brufal M, et al. Bronchial exudate of serum proteins during asthma attack. Arch Bronconeumol 2005;41(6):328-33. https://doi.org/10.1016/s1579-2129(06)60232-2 PMid:15989890

Büyüköztürk S, Gelincik AA, Genç S, Koçak H, Oneriyidogan Y, Erden S, et al. Acute phase reactants in allergic airway disease. Tohoku J Exp Med. 2004;204:209-13. https://doi.org/10.1620/tjem.204.209 PMid:15502420

Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol. 2002;89(4):381-5. https://doi.org/10.1016/s1081-1206(10)62039-x PMid:12392382

Adams BK, Cydulka RK. Asthma evaluation and management. Emerg Med Clin North Am 2003;21(2):315-30. PMid:12793616

Weiss EB, Desforges JF. Oxyhemoglobin affinity in bronchial asthma: Chronic stable state, acute, and status asthmaticus. Chest. 1972;62(6):709-16. https://doi.org/10.1378/chest.62.6.709 PMid:4635420.

Guo CH, Liu PJ, Lin KP, Chen PC. Nutritional supplement therapy improves oxidative stress, immune response, pulmonary function, and quality of life in allergic asthma patients: An open-label pilot study. Altern Med Rev. 2012;17(1):42-56. PMid:22502622

Hailemaryam T, Adissu W, Gedefaw L, Asres Y. Hematological profiles among asthmatic patients in Southwest Ethiopia: A comparative cross-sectional study. Hematol Transfus Int J. 2018;6(2):77-82. https://doi.org/10.15406/htij.2018.06.00157

Ejaz S, Nasim F, Ashraf M, Ahmad S. Hematological and biochemical profile of patients suffering from non-atopic asthma. Insights Chest Dis. 2017;2:2. https://doi.org/10.21767/2577-0578.10006

Ge RL, Witkowski S, Zhang Y, Alfrey C, Sivieri M, Karlsen T, et al. Determinants of erythropoietin release in response to short-term hypobaric hypoxia. J Appl Physiol (1985). 2002;92:2361-7. https://doi.org/10.1152/japplphysiol.00684.2001 PMid:12015348

Published
2020-03-05
How to Cite
1.
Abd Al-Aziz AM, Shaaban H, Talaat A, Awad MAM, Ali R, A. Shahin W. Assessment of Ceruloplasmin, Hemopexin, and Haptoglobin in Asthmatic Children. Open Access Maced J Med Sci [Internet]. 2020Mar.5 [cited 2020Oct.23];8(B):31-7. Available from: https://www.id-press.eu/mjms/article/view/3728